161 Startups
  • Sector
  • Participated in
  • Year of participation

NephroClear

  • 2024
  • Enabling Technology
  • Venture Challenge
Nephroclear developed a break-through technology in renal clearance modelling, catering to high unmet needs in the global pharmaceutical industry to better predict dosing regimens of new drug candidates.

NestEgg Labs

  • 2022
  • Enabling Technology
  • Venture Challenge
At NestEgg Labs, we simplify 3D cell culture through automation. We have developed Ovation, an automated platform capable of combining Lens-Free Imaging technology for constant cell monitoring and flexible fluid handling for cell maintenance inside a controlled environment, letting cells grow without unnecessary manual interference.

NeuroGut Insights

  • 2024
  • Enabling Technology
  • Venture Challenge
NeuroGut Insights is the go-to service company to address any questions on the effect of intestinal components on healthy brain development.

NeuroNova Tx

  • 2025
  • Therapeutics
  • Venture Challenge
Term babies suffering from early life brain injury (hypoxic-ischemic brain injury (HIBI)) are at high-risk of neurological consequences. There are currently no effective therapies for the >12.000 cases annually in the 5 major markets in the EU and US combined.

NeuroTidal Dx

  • 2024
  • Venture Challenge
At NeuroTidal Dx we provide a novel for objective measurement and earlier detection of Parkinson's Disease.

Nightbalance

  • Medical Device
  • Venture Challenge
NightBalance is a compact, easy-to-use maskless treatment against positional OSA. you wear the small device comfortably on your chest in a soft, adjustable chest strap.

Novioscan

  • 2015
  • Medical Device
  • Venture Challenge
The SENS-U KIDS is a small wearable device that provides warning when the bladder is nearly full. SENSE-U KIDS helps children to stay dry during day and night and will improve the effectiveness of continence training by teaching the child the sensation of a full bladder.

Novuxion

  • 2022
  • Diagnostics
  • Venture Challenge
Novuxion offers a non-invasive, inexpensive method of testing patients. We aim to provide in vitro diagnostic technology to enable (early) detection of metastatic cancer, patient monitoring, and therapy adjustment.

Novya Biotech

  • 2024
  • Enabling Technology
  • Venture Challenge
Novya Biotech accelerates yeast-based production platforms with a groundbreaking CRISPR-based technology, enabling faster and more cost-effective production of complex pharmaceutical compounds.

NTRC

  • 2010
  • Therapeutics
  • Venture Challenge
Small Molecules for Targeted Anti-Cancer Therapy